CD8 beta Blocking Peptide for STJ505976 peptide (STJ505748) STJ505748-250 上海玉博生物科技有限公司

CD8 beta Blocking Peptide for STJ505976 peptide (STJ505748)

如果您对该产品感兴趣的话，可以
产品名称：CD8 beta Blocking Peptide for STJ505976 peptide (STJ505748)
产品型号：STJ505748-250
产品展商：ST john's laboratory
产品文档：无相关文档

简单介绍

CD8 beta Blocking Peptide for STJ505976 peptide (STJ505748)

产品描述

Applications:	Immunodepletion/Immunocompetition
Note:	STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	CD8 beta Blocking Peptide for STJ505976 is synthetically produced from the 70-120 sequence and is suitable for use in western blot applications.

Formulation:	Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage Instruction:	Store at-20°C for long term storage. Avoid freeze-thaw cycles.

Gene Symbol:	CD8B
Gene ID:	926
Uniprot ID:	CD8B_HUMAN
Immunogen Region:	70-120
Specificity:	This blocking peptide is recommended for use in combination with CD8 beta antibody, STJ505976
Immunogen:	Synthetic peptide taken within amino acid region 70-120 on human T-cell surface glycoprotein CD8 Beta chain.

Post Translational Modifications	Phosphorylated as a consequence of T-cell activation. Palmitoylated at the cytoplasmic tail and thereby targets the heterodimer CD8A/CD8B to lipid rafts unlike CD8A homodimers.
Function	Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class I molecule:peptide complex. The antigens presented by class I peptides are derived from cytosolic proteins while class II derived from extracellular proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class I proteins presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. A palmitoylation site in the cytoplasmic tail of CD8B chain contributes to partitioning of CD8 into the plasma membrane lipid rafts where signaling proteins are enriched. Once LCK recruited, it initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of cytotoxic T-lymphocytes (CTLs). Additionally, plays a critical role in thymic selection of CD8+ T-cells.
Peptide Name	T-Cell Surface Glycoprotein Cd8 Beta Chain Cd Antigen Cd8b
Database Links	Reactome: R-HSA-182218 Reactome: R-HSA-198933
Cellular Localisation	Isoform 1: Cell Membrane Single-Pass Type I Membrane Protein Requires The Partner Cd8a For Efficient Cell Surface Expression The Heterodimer Cd8a/Cd8b Localizes To Lipid Rafts Due To Cd8b Cytoplasmic Tail Palmitoylation Isoform 2: Cell Membrane Isoform 3: Secreted Isoform 4: Cell Membrane Isoform 5: Cell Membrane Isoform 6: Secreted Isoform 7: Secreted Isoform 8: Secreted
Alternative Peptide Names	T-Cell Surface Glycoprotein Cd8 Beta Chain protein Cd Antigen Cd8b protein CD8B protein CD8B1 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报

产品目录

产品资料

CD8 beta Blocking Peptide for STJ505976 peptide (STJ505748)